Procter & Gamble Health Limited Holds 59th AGM; Discusses FY26 Performance
Procter & Gamble Health Limited held its 59th AGM on September 3, 2026. The company reported a 16% increase in sales and a 30% increase in PAT for FY 2025-26. Key resolutions included dividend declaration and director re-appointments. Productivity savings of ₹35 crore were achieved.
The AGM proceedings and financial performance update are important for shareholders and investors, impacting their perception of the company's health and future prospects, but do not represent a transformative event.
The announcement highlights strong financial performance with significant increases in sales and PAT, along with strategic initiatives and dividend declarations, indicating positive business momentum.
Procter & Gamble Health Limited (PGHL) held its 59th Annual General Meeting (AGM) on September 3, 2026, commencing at 2:30 p.m. IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting was chaired by Mr. S Madhavan, who welcomed shareholders and introduced the board members and management officials.
During the AGM, an overview of the company's business performance for the financial year 2025-26 was presented. The company reported a strong year with a 16% increase in sales and a 30% increase in Profit After Tax (PAT). The financial year, which was a 9-month period from July 1, 2024, to March 31, 2025, saw its performance indexed against the comparable 12-month period of the previous year. The company highlighted its integrated growth strategy focusing on Superiority, Portfolio, Constructive Disruption, Productivity, and an Empowered Organization.
Key resolutions discussed included the adoption of the Audited Balance Sheet as at March 31, 2026, and the Statement of Profit and Loss for the Financial Year ended on that date. Shareholders also voted on confirming the payment of interim dividend and declaring a final dividend for FY 2025-26. Resolutions also pertained to the re-appointment of Mr. Aalok Agrawal as a director retiring by rotation and the re-appointment of Mr. S. Madhavan as a Non-Executive Independent Director for a period of five years effective November 15, 2026. Additionally, the remuneration payable to the Cost Auditor for FY 2026-27 was ratified.
The company reported productivity savings of ₹35 crores for FY 2025-26. Management also responded to shareholder queries regarding the financial accounts and the annual report. The results of the e-voting, which commenced on August 31, 2026, and concluded on September 2, 2026, with an extension for in-meeting voting, were to be announced within 2 working days of the meeting's conclusion. The AGM concluded at 3:55 p.m. IST.
A plain-language summary of a public exchange filing by Procter & Gamble Health Limited. Read the original for the full detail.